NASDAQ : STIM
Neuronetics, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 2.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.44M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 156.97M |
| Enterprise Value | 224.29M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 76.20M |
| Shares Outstanding | 76.20M |
| Shares Change (YoY) | +42.95% |
| Shares Change (QoQ) | +5.09% |
| Owned by Insiders (%) | 19.88% |
| Owned by Institutions (%) | 24.63% |
| Float | 37.15M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.01 |
| Forward PS | 0.93 |
| PB Ratio | 8.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.88 |
| Quick Ratio | 1.25 |
| Debt / Equity | 4.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.52 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -116.10% |
| Return on Assets (ROA) | -10.55% |
| Return on Invested Capital (ROIC) | -12.74% |
| Return on Capital Employed (ROCE) | -21.76% |
| Weighted Average Cost of Capital (WACC) | 9.88% |
| Revenue Per Employee | $235,708 |
| Profits Per Employee | -$46,249 |
| Employee Count | 658 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 15.03 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -22.26% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 41.93 |
| Average Volume (20 Days) | 676,642 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.21M |
| Short Previous Month | 7.07M |
| Short % of Shares Out | 9.46% |
| Short % of Float | 19.41% |
| Short Ratio (days to cover) | 8.30 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 155.10M |
| Gross Profit | 76.59M |
| Operating Income | -22.46M |
| Pretax Income | -30.85M |
| Net Income | -30.43M |
| EBITDA | -19.26M |
| EBIT | -22.46M |
| Loss Per Share | -$0.44 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 19.20M |
| Total Debt | 86.52M |
| Net Cash | -67.33M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | 21.64M |
| Book Value Per Share | 0.23 |
| Working Capital | 24.92M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -10.31M |
| Capital Expenditures | -944,000 |
| Depreciation & Amortization | 3.20M |
| Net Borrowing | 4.79M |
| Free Cash Flow | -11.25M |
| FCF Per Share | -$0.15 |
Margins
| Measure | Value |
|---|
| Gross Margin | 49.38% |
| Operating Margin | -14.48% |
| Pretax Margin | -19.89% |
| Profit Margin | -19.62% |
| EBITDA Margin | -12.42% |
| EBIT Margin | -14.48% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -42.95% |
| Shareholder Yield | -42.95% |
| Earnings Yield | -21.19% |
| FCF Yield | -7.17% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.75 |
| Price Target Difference | 179.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 8.74% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.39 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |